Augmedix, Inc. (AUGX) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Healthcare Information Services Branche. Der Hauptsitz des Unternehmens ist in San Francisco, CA, United States. Der aktuelle CEO ist Emmanuel Krakaris.
AUGX hat IPO-Datum 2021-03-31, 1,430 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $115.91M.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
